Breast cancer and incidence of type 2 diabetes mellitus: a systematic review and meta-analysis

CONCLUSION: Our findings suggest an elevated risk of T2D in breast cancer survivors, particularly after tamoxifen therapy. Further research is needed to determine the impact of aromatase inhibitors, and chemotherapy on the incidence of T2D after breast cancer.PMID:37656235 | DOI:10.1007/s10549-023-07043-6

Source: Clinical Breast Cancer - September 1, 2023 Category: Cancer & Oncology Authors: Nanna Jordt Kasper Aalb æk Kjærgaard Reimar W Thomsen Signe Borgquist Deirdre Cronin-Fenton Source Type: research